Clinical trial Recruiting at 1 site Interventional Ages 18 to 69

Remote exercise program to improve blood sugar control and fitness in adults with type 2 diabetes

Official title: A 12 Weeks Clinical Trail to Evaluate the Effect of Remote Exercise Intervention on Blood Glucose Control and Physical Fitness in T2DM Patients

Run by Sichuan Academy of Medical Sciences · NCT07676773 · Data updated 2026-11-12

A remote 12‑week exercise program plus health education is tested in adults with type 2 diabetes to see if it improves blood sugar control and physical fitness.

Quick facts

Study typeInterventional
Ages18 Years to 69 Years
SexAll
Enrollment80 (estimated)
SponsorSichuan Academy of Medical Sciences
Academic / other
Locations1 site (Chengdu, Sichuan)
StatusRecruiting
StartedJune 1, 2026
Main results expectedAugust 31, 2026
Study endsDecember 31, 2026
Registry record updatedJune 30, 2026
Trial IDNCT07676773 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults aged 40–69 with newly diagnosed type 2 diabetes (≤5 years), HbA1c 6.5–7.0%, not on antidiabetic medications, and suitable for remote exercise participation.

Probably not a fit

Individuals with diabetes requiring medications or with contraindications to exercise or high exercise risk may not benefit from this program.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This interventional study compares a remote exercise intervention plus health education to health education alone over 12 weeks in adults aged 40-69 with type 2 diabetes. Participants in the intervention group perform 5–7 weekly sessions of walking, running, aerobic exercise, and swimming, with progressive intensity based on VO2R, plus resistance training 2–3 times weekly; the control group receives equivalent health education but without the structured remote exercise. Heart rate and perceived exertion are monitored, and sessions include warm-up and cooldown. Eligibility requires recent diabetes diagnosis (≤5 years), HbA1c 6.5–7.0%, and no antidiabetic medications, among other safety criteria. The study aims to determine whether remote, structured exercise can better improve glycemic control and cardio-respiratory fitness than education alone.

Why it matters

Potential benefit: If successful, participants may achieve better blood sugar control and improved fitness with a remotely guided exercise program.

How similar studies have gone: Prior studies suggest that remote or home-based exercise programs can improve glycemic outcomes and fitness, though results vary by population and protocol.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

(1) Both gender, age from 40 to 69 years old. (2) Meeting the diagnostic criteria for type 2 diabetes in China. (3) HbA1c is within 6.5%-7 .0% and no medication is taken. (4) Newly diagnosed with diabetes or the duration of the disease is no more than 5 years. (5) Possessing general exercise capacity and no obvious diseases in the muscle and osteoarticular systems. (6) The exercise risk is evaluated as medium or low risk through the PAR-Q+ questionnaire. (7) No contraindications to exercise tests. (8) Willing to adopt intensifed lifestyle intervention and complete the entire research process.

Exclusion Criteria:

(1) T1DM patients, autoimmune diabetes and special types of diabetes, including hypercortisolism, growth hormone tumor, glucagonoma and some special types of diabetes caused by genetic factors; (2) pregnant or lactating women; (3) regular use of antidiabetic drugs or insulin in the past three months; (4) fasting blood glucose level \> 16.7 mmol/L; (5) recurrent hypoglycemia; (6) a history of acute diabetic complications, including diabetic ketoacidosis, hyperosmolar hyperglycemia, and lactic acidosis; (7) a history of severe chronic microvascular or macrovascular complications; (8) diseases that may be exacerbated by exercise or impair exercise efciency, such as uncontrolled hypertension, hyperthyroidism, osteoarthritis or hypokalemia; (9) unable to use smart phones or wearable smart devices independently; (10) communication or motor dysfunction; (11) Patients with severe chronic diseases could not participate in the study.

Where it's running

  • Sichuan Provinvial People's HSichuan Academy of Medical Sciences & Sichuan Provincial People's Hospital( SAMS&SPPH,Affiliated Hospital of UESTC)ospital
    Chengdu, Sichuan, China
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.